BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cylene Pharmaceuticals, Inc. 

5820 Nancy Ridge Drive, Suite 200

San Diego  California  92121  U.S.A.
Phone: 858-875-5100 Fax: 858-875-5101


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Cylene Pharmaceuticals, Inc. and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies 3/6/2013 9:32:34 AM
New Drug Stunts Tumor Growth, Cylene Pharmaceuticals, Inc. Reveals 7/18/2012 7:46:19 AM
Cylene Pharmaceuticals, Inc. Release: Cancer Cell Article Demonstrates First Definitive Evidence for Targeting of Pol I as New Approach to Cancer Therapy 7/10/2012 10:59:18 AM
Cylene Pharmaceuticals, Inc. Builds on Success, Presents Second CK2 Inhibitor at American Association for Cancer Research Meeting 4/4/2012 9:37:38 AM
Cylene Pharmaceuticals, Inc. Builds on Success, Presents Second CK2 Inhibitor at American Association for Cancer Research Meeting 4/3/2012 11:24:27 AM
Cylene Pharmaceuticals, Inc. First-in-Class Agents Show Promise in High Risk Blood Cancers at American Society of Hematology 12/13/2011 11:04:14 AM
Cylene Pharmaceuticals, Inc. Advances Breakthrough p53 Activator Toward the Clinic 10/13/2011 10:29:55 AM
Cylene Pharmaceuticals, Inc. Presents Encouraging Clinical Data for Oral CK2 Inhibitor at American Society of Clinical Oncology 6/6/2011 10:23:59 AM
Cylene Pharmaceuticals, Inc. Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hypertension Meeting 12/6/2010 7:59:54 AM
Cylene Pharmaceuticals, Inc. to Present Advances with Industry's Only Clinical CK2 Inhibitor, CX-4945, at EORTC-NCI-AACR 11/16/2010 7:29:26 AM
1234